Tempest Therapeutics (TPST) Earnings Date, Estimates & Call Transcripts $6.96 +0.74 (+11.90%) As of 04:00 PM Eastern Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Tempest Therapeutics Earnings Summary Upcoming Earnings DateMay. 8Before Market OpensEstimatedConsensus EPS (Mar. 27) -$3.12 Actual EPS (Mar. 27) -$4.03 Missed By -$0.91 Actual Revenue (Mar. 27) $0.49MTempest Therapeutics posted Q4 2024 earnings on March 27, 2025, reporting an EPS of -$4.03, which missed analysts' consensus estimates of -$3.12 by $0.91. Quarterly revenue was reported to be $0.49 million. With a trailing EPS of -$19.51, Tempest Therapeutics' earnings are expected to grow next year, from ($1.39) to ($1.05) per share. Q4 2024 Earnings ResourcesQ4 2024 Earnings Report Press Release (8-K) Annual Report (10-K)TPST Upcoming EarningsTempest Therapeutics' Q1 2025 earnings is scheduled for Thursday, May 8, 2025, with a conference call scheduled at 4:00 PM ET. Check back for transcripts, audio, and key financial metrics as they become available.Q1 2025 Earnings ReportPowered by Get Tempest Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Tempest Therapeutics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataTPST Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter. Remove Ads Tempest Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20252-$4.42-$4.03-$4.23Q2 20251-$4.55-$4.55-$4.55Q3 20251-$4.94-$4.94-$4.94Q4 20251-$5.46-$5.46-$5.46FY 20255($19.37)($18.98)($19.18) Remove Ads Tempest Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 5/8/2025(Estimated)-------3/27/2025Q4 2024-$3.12-$4.03 -$0.91-$0.31-$0.49M11/12/2024--$4.81-$5.33 -$0.52-$0.41--8/8/2024--$6.11-$5.46+$0.65-$0.42--5/9/2024Q1 2024-$5.72-$4.68+$1.04-$0.36--3/19/2024Q4 2023-$4.94-$4.42+$0.52-$0.34--11/8/2023Q3 2023-$7.15-$6.24+$0.91-$0.48--8/10/2023Q2 2023-$7.54-$7.02+$0.52-$0.54--5/10/2023Q1 2023-$8.58-$7.15+$1.43-$0.55-- Tempest Therapeutics Earnings - Frequently Asked Questions When is Tempest Therapeutics's earnings date? Tempest Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 8th, 2025 based off last year's report dates. Learn more on TPST's earnings history. Did Tempest Therapeutics beat their earnings estimates last quarter? In the previous quarter, Tempest Therapeutics (NASDAQ:TPST) missed the analysts' consensus estimate of ($3.12) by $0.91 with a reported earnings per share (EPS) of ($4.03). Learn more on analysts' earnings estimate vs. TPST's actual earnings. How much profit does Tempest Therapeutics generate each year? Tempest Therapeutics (NASDAQ:TPST) has a recorded net income of -$29.49 million. TPST has generated -$19.51 earnings per share over the last four quarters. What is Tempest Therapeutics's EPS forecast for next year? Tempest Therapeutics's earnings are expected to grow from ($1.39) per share to ($1.05) per share in the next year. More Earnings Resources from MarketBeat Related Companies BioHarvest Sciences Earnings Date OptiNose Earnings Date Instil Bio Earnings Date Coya Therapeutics Earnings Date Oramed Pharmaceuticals Earnings Date Immunic Earnings Date Climb Bio Earnings Date CervoMed Earnings Date Galectin Therapeutics Earnings Date Atossa Therapeutics Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Why Analysts Boosted United Airlines Stock Ahead of EarningsLamb Weston Stock Rises, Earnings Provide Calm Amidst ChaosIntuitive Machines Gains After Earnings Beat, NASA Missions AheadCintas Delivers Earnings Beat, Signals More Growth AheadNike Stock Dips on Earnings: Analysts Weigh in on What’s NextAfter Massive Post Earnings Fall, Does Hope Remain for MongoDB?Semtech Rallies on Earnings Beat—Is There More Upside? Remove Ads This page (NASDAQ:TPST) was last updated on 4/14/2025 by MarketBeat.com Staff From Our PartnersWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredClaim Your FREE Protection GuideIn the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hid...American Alternative | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredTariffs. Volatility. Fear. Here’s the Plan.Wall Street's panicking over tariffs. Volatility's back with a vengeance. If you've been glued to the he...Investors Alley | SponsoredCatastrophicThe losses are catastrophic... $760 billion wiped off the Magnificent 7, in a single day.InvestorPlace | SponsoredTrump’s betrayal exposed Whether you agree with the plan or not doesn’t matter. It’s happening. The only question is – are you re...Porter & Company | SponsoredTrump 2028 could be a “bonanza” for investorsAs you may have heard, Donald Trump is planning to run for a THIRD term in 2028. Recently he told NBC news ...Paradigm Press | SponsoredIf Gold Is ‘Stalling,’ Why Are Banks Hoarding Billions In Secret?Prosperity was something every American family could build, protect, and pass down. Because that's what legacy...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tempest Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tempest Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy TPST Stock Free TPST Stock Alerts